How many insider trades does FilingIQ track for GRX?

FilingIQ tracks 114 Form 4 insider transactions for GRX (GABELLI HEALTHCARE & WELL), covering filings from Jun 8, 2016 onwards. 3 of those were filed in the last 90 days.

Are GRX insiders net buyers or net sellers?

Across the full Form 4 history for GRX, 94 transactions (82%) were open-market purchases and 19 (17%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does GRX insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is GRX in?

GABELLI HEALTHCARE & WELL (GRX) is classified in the Financial Services sector, specifically Asset Management, with a current market capitalisation of $138.32M.

GRX insider trading

NYSE Financial Services

GABELLI HEALTHCARE & WELL — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

114

Last 90 days

Buys / sells

82% / 17%

Market cap

$138.32M

About GABELLI HEALTHCARE & WELL

The Gabelli Healthcare and Wellness Trust is a closed-ended equity mutual fund launched by GAMCO Investors, Inc. The fund is managed by Gabelli Funds, LLC. It invests in the public equity markets across the globe. The fund seeks to invest in stocks of companies primarily operating in the healthcare and wellness sector. It invests in stocks of companies across all market capitalizations. The fund benchmarks the performance of its portfolio against the S&P 500 Index, S&P 500 Consumer Staples Index, and S&P 500 Health Care Index. The Gabelli Healthcare & Wellness Trust was formed on February 20, 2007 and is domiciled in the United States.

Company website: www.gabelli.com

GRX insider activity at a glance

FilingIQ has scored 114 insider transactions for GRX since Jun 8, 2016. The most recent filing in our index is dated Aug 19, 2026.

Across the full history, 94 open-market purchases and 19 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on GRX insider trades is 44.9/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live GRX trades on FilingIQ

Other Financial Services tickers with recent insider activity

WAL 229

WESTERN ALLIANCE BANCORPORATION

CRCL 222

Circle Internet Group, Inc.

CACC 196

CREDIT ACCEPTANCE CORP

MIAX 168

MIAMI INTERNATIONAL HOLDINGS, INC.

LIFE 119

Ethos Technologies Inc.

MFG 115

MIZUHO FINANCIAL GROUP INC

HOOD 107

Robinhood Markets, Inc.

SLQT 103

SelectQuote, Inc.

Frequently asked

How many insider trades does FilingIQ track for GRX?: FilingIQ tracks 114 Form 4 insider transactions for GRX (GABELLI HEALTHCARE & WELL), covering filings from Jun 8, 2016 onwards. 3 of those were filed in the last 90 days.
Are GRX insiders net buyers or net sellers?: Across the full Form 4 history for GRX, 94 transactions (82%) were open-market purchases and 19 (17%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does GRX insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is GRX in?: GABELLI HEALTHCARE & WELL (GRX) is classified in the Financial Services sector, specifically Asset Management, with a current market capitalisation of $138.32M.

Methodology & sources

Every GRX insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.